Bexley Pharmaceuticals Private Limited
About Bexley Pharmaceuticals Private Limited
Data last updated:
Bexley Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 13 August 2024.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U47721DL2024PTC435466.
The company has an authorised share capital of ₹50,000 and a paid-up capital of ₹50,000. It is led by directors Rakhi Chawla and Sandeep Kumar.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wz 112A Ground Floor, Street No 10 Krishna Park, New Delhi, Delhi, India – 110018.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.16 Lakh. For the same year it recorded a net loss of ₹9,911 (net margin -0.8%) and EBITDA of ₹38,776 (EBITDA margin 3.2%).
Company details
Contact details
Bexley Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressWz 112A Ground Floor, Street No 10 Krishna Park, New Delhi, Delhi, India – 110018
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bexley Pharmaceuticals Private Limited
FY 2025 filings availableBexley Pharmaceuticals Private Limited reported revenue of ₹12.16 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹38,776 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹9,911 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | 3.2% |
| Net Profit Margin | -0.8% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Bexley Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bexley Pharmaceuticals Private Limited
Bexley Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakhi Chawla | Director | 13 Aug 2024 | 2 Years 2 Months | Current |
| Sandeep Kumar | Director | 13 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Bexley Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Moseley Pharmaceuticals Private Limited | ₹12.2 Lakh (FY 2025) | -59.0% | Lucknow, Uttar Pradesh, India | |||
| Riddhi Pharmaceuticals Limited | ₹12.2 Lakh (FY 2025) | 460139.0% | Mumbai, Maharashtra, India | |||
| Cocoon Pharmaceuticals Private Limited | ₹12.18 Lakh (FY 2022) | Titwala, Maharashtra, India | ||||
| Savioris Pharmaceuticals Private Limited | ₹12.17 Lakh (FY 2025) | 42.0% | Jaipur, Rajasthan, India | |||
| Kotac Pharmaceuticals Private Limited | ₹12.17 Lakh (FY 2024) | -58.0% | Budaun, Uttar Pradesh, India | |||
| Bexley Pharmaceuticals Private Limitedthis company | ₹12.16 Lakh (FY 2025) | -₹9,911 | -0.8% | New Delhi, Delhi, India | ||
| Rimax Pharmaceuticals Private Limited | ₹12.11 Lakh (FY 2024) | 1.0% | Ghaziabad, Uttar Pradesh, India | |||
| Siddson Pharmaceuticals Private Limited | ₹12.11 Lakh (FY 2025) | Belgaum, Karnataka, India | ||||
| Dossier Pharmaceuticals Private Limited | ₹12.07 Lakh (FY 2018) | 108.0% | Pune, Maharashtra, India | |||
| Souris Pharmaceuticals Private Limited | ₹12.06 Lakh (FY 2025) | -7.0% | Bangalore, Karnataka, India | |||
| Zeinac Pharmaceuticals Private Limited | ₹12.05 Lakh (FY 2024) | 47.0% | Bareilly, Uttar Pradesh, India |
To see the full peer comparison of Bexley Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bexley Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bexley Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bexley Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bexley Pharmaceuticals Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Rakhi Chawla was appointed as Director on 13 Aug 2024.
Frequently asked questions
Bexley Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 13 August 2024 (2+ years old) and is registered under CIN U47721DL2024PTC435466.
Bexley Pharmaceuticals has 2 current directors:
- Rakhi Chawla - Director
- Sandeep Kumar - Director
The latest financial statements of Bexley Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Bexley Pharmaceuticals is U47721DL2024PTC435466. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bexley Pharmaceuticals was incorporated on 13 August 2024, making it 2+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Bexley Pharmaceuticals by revenue are Moseley Pharmaceuticals Private Limited, Riddhi Pharmaceuticals Limited, Cocoon Pharmaceuticals Private Limited, Savioris Pharmaceuticals Private Limited, Kotac Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Rakhi Chawla was appointed as Director on 13 Aug 2024. Sandeep Kumar was appointed as Director on 13 Aug 2024.
The registered office of Bexley Pharmaceuticals is at Wz 112A Ground Floor, Street No 10 Krishna Park, New Delhi, Delhi, India – 110018.
Bexley Pharmaceuticals can be reached at its registered office: Wz 112A Ground Floor, Street No 10 Krishna Park, New Delhi, Delhi, India – 110018.
Bexley Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
